Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT06930807Not ApplicableRecruiting
Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer
Adaptive TreatmentMinimal Residual DiseaseNon-small Cell Lung Cancer
PrincipalinvestigatorStart date: 2025-03-25

Research Network

Collaboration Network

18 collaborators·55 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Shenzhen Third People's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Xiaojun Zhu, PhD

China National Institute for Occupational Safety and Health (NIOSH/CDC)

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Ziming Li, MD

Shanghai Chest Hospital

Moderately Similar
2 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungAdaptive TreatmentNeoplasm, Residual

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Kezhong Chen, MD

Peking University People's Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

Carcinoma, Non-Small-Cell LungAdaptive TreatmentNeoplasm, Residual

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Jun Yin, MD

Shanghai Zhongshan Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Rong Yin, MD

Jiangsu Cancer Institute & Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Yuan Cheng, MD

Peking University First Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Yintao Li, MD

Shandong Cancer Hospital and Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Quanfu Huang, MD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Jiatao Zhang, MD

Guangdong Provincial People's Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Fang Wu, MD

Second Xiangya Hospital of Central South University

Moderately Similar
1 trials

Shared therapeutic areas:

Adaptive TreatmentNeoplasm, ResidualCarcinoma, Non-Small-Cell Lung

Worked with same sponsors:

Guangdong Provincial People's HospitalJiangsu Cancer Institute & Hospital+10 more
Collaborated on 1 trial
Similarity Score34%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT06930807Not ApplicablePrincipalInvestigator

Liquid Biopsy-Based Novel Modality for Postoperative Management of Lung Cancer

Adaptive TreatmentMinimal Residual DiseaseNon-small Cell Lung Cancer
Recruiting

All 1 trials loaded